Birmingham, West Midlands -- (SBWIRE) -- 12/11/2013 -- Value Penny Stocks issues special report on Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Myriad Genetics, Inc. (NASDAQ:MYGN), Aruba Networks, Inc. (NASDAQ:ARUN), VIVUS, Inc. (NASDAQ:VVUS).
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) opened its last trade at the price of $5.81. Its closing price was $5.79 after losing -0.52% for the day. The company traded with the total volume of 2,324,669 shares, while its average trading volume remained 6.01 million shares. The beta of this stock stands at -0.39. Arena Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases.
Has ARNA Found The Bottom and Ready To Move Up? Find Out Here
Myriad Genetics, Inc. (NASDAQ:MYGN) percentage change plunged -2.73% to close at $24.07 with the total traded volume of 2,308,986 shares, along with average volume of 2.44 million shares. The 52 week range of the stock remained $22.20 - $38.27, while its day lowest price was $23.66. The share price hit the day highest price of $24.68. Myriad Genetics, Inc., a molecular diagnostic company, focuses on the development and marketing of predictive medicine, personalized medicine, and prognostic medicine tests primarily in the United States.
Has MYGN Found The Bottom And Ready To Gain Momentum? Find Out Here
Aruba Networks, Inc. (NASDAQ:ARUN) traded on volume of 2,289,508 shares in the last session against average volume of 2.24 million shares. The company started its trading session with the price of $17.42 and closed at $16.81 by scoring -3.94%. Aruba Networks, Inc. provides network access solutions for the mobile enterprises worldwide. It offers ArubaOS, an operating system software for wired, wireless, and remote access products for integrating user-based security, application-aware radio-frequency services.
Why Should Investors Buy ARUN After the Recent Fall? Just Go Here and Find Out
VIVUS, Inc. (NASDAQ:VVUS) started its last trading session with the price of $9.66 and closed at $9.63 by scoring -0.41%. The stock traded with total volume of 2,276,017 shares, while the average trading volume remained 1.87 million shares. The beta value of this stock stands at 1.33. Day range for the stock was $9.49 - $10.08. VIVUS, Inc., a biopharmaceutical company, engages in developing and commercializing therapies to address unmet needs in obesity, sleep apnea, diabetes, and sexual health.
Will VVUS Get Buyers Even After The Recent Rally? Find Out Here
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)